Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure
- PMID: 35362244
- PMCID: PMC9314678
- DOI: 10.1002/hec.4500
Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure
Abstract
This study measures the increment of health care expenditure (HCE) that can be attributed to technological progress and change in medical practice by using a residual approach and microdata. We examine repeated cross-sections of individuals experiencing an initial health shock at different point in time over a 10-year window and capture the impact of unobservable technology and medical practice to which they are exposed after allowing for differences in health and socioeconomic characteristics. We decompose the residual increment in the part that is due to the effect of delaying time to death, that is, individuals surviving longer after a health shock and thus contributing longer to the demand of care, and the part that is due to increasing intensity of resource use, that is, the basket of services becoming more expensive to allow for the cost of innovation. We use data from the Danish National Health System that offers universal coverage and is free of charge at the point of access. We find that technological progress and change in medical practice can explain about 60% of the increment of HCE, in line with macroeconomic studies that traditionally investigate this subject.
Keywords: aging; health care expenditure; morbidity; technological; time-to-death.
© 2022 The Authors. Health Economics published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors disclose no conflict of interest.
Figures



Similar articles
-
Ageing and health care expenditures: the importance of age per se, steepening of the individual-level expenditure curve, and the role of morbidity.Eur J Health Econ. 2022 Sep;23(7):1121-1149. doi: 10.1007/s10198-021-01413-x. Epub 2022 Jan 17. Eur J Health Econ. 2022. PMID: 35037122
-
Health expenditure growth: reassessing the threat of ageing.Health Econ. 2006 Sep;15(9):947-63. doi: 10.1002/hec.1165. Health Econ. 2006. PMID: 16958079
-
Gender Difference in Health-Care Expenditure: Evidence from India Human Development Survey.PLoS One. 2016 Jul 8;11(7):e0158332. doi: 10.1371/journal.pone.0158332. eCollection 2016. PLoS One. 2016. PMID: 27391322 Free PMC article.
-
Measuring integrated care.Dan Med Bull. 2011 Feb;58(2):B4245. Dan Med Bull. 2011. PMID: 21299927 Review.
-
[Literature review regarding the impact of population aging on healthcare expenditure growth: Organisation for Economic Co-operation and Development member countries and Morocco].Pan Afr Med J. 2018 Oct 25;31:142. doi: 10.11604/pamj.2018.31.142.15248. eCollection 2018. Pan Afr Med J. 2018. PMID: 31037202 Free PMC article. Review. French.
References
-
- Acemoglu, D. , & Linn, J. (2004). Market size in innovation: Theory and evidence from the pharmaceutical industry. The Quarterly Journal of Economics, 119(3), 1049–1090. 10.1162/0033553041502144 - DOI
-
- Chernew, M. E. , & Newhouse, J. P. (2011). Health care spending growth. In Pauly M. V., Mcguire T. G., & Barros P. P. (Eds.), Handbook of health economics. Elsevier.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources